Covation's New Plant Signals Major Shift to Bio-Based Materials

SHANGHAI, China – April 20, 2026 – A significant step toward weaning high-performance materials off fossil fuels was taken today as Covation Biomaterials announced the mechanical completion of its first commercial bio-materials plant in Qidong, China. The facility, a cornerstone of a planned RMB 10 billion investment, is set to begin producing bio-based alternatives for key industrial chemicals in the second half of 2026, marking a pivotal moment in the industry's push for sustainability.

Concurrent with the plant's completion, the Delaware-based company, which was founded in 2022 building on a legacy of DuPont innovation, officially launched Xatryx®, its new brand for bio-based polytetramethylene ether glycol (bioPTMEG). This material is a critical component in products ranging from spandex fibers used in activewear to durable polyurethane elastomers found in automotive parts and footwear. The new plant will produce Xatryx® alongside its chemical precursor, bio-based tetrahydrofuran (bioTHF), with an initial annual capacity of 50,000 tons.

This development positions Covation Biomaterials as a major new force in a rapidly growing market, directly challenging petroleum-based incumbents with a scalable, renewable alternative.

A New Era for High-Performance Polymers

The core of Covation's strategy lies in its "Advanced ThermoChemical technology," which the company describes as an innovative, new-to-the-world process. This technology is designed to create high-performance materials from renewable, non-food feedstocks, offering a direct, sustainable replacement for their fossil-based counterparts.

For decades, PTMEG has been an essential building block for manufacturing materials that require a unique combination of strength, flexibility, and durability. Its production has traditionally relied on petrochemicals. Covation’s Xatryx® bioPTMEG is engineered as a "drop-in" replacement, a crucial feature that allows downstream manufacturers of spandex, polyurethanes, and thermoplastic elastomers to switch to a bio-based raw material without costly changes to their existing processes or compromising the final product's performance.

"The Xatryx® name conveys our spirit of relentless exploration to develop processes and products that deliver high performance and support defossilization of the materials industry," said Feifeng You, President of CovationBio, in a statement. "As an important building block, Xatryx® products provide many possibilities to improve one's quality of life while taking good care of our planet."

The Sustainability Promise: From Corncobs to Spandex

Central to the appeal of Xatryx® is its origin story. The material is produced using second-generation bio-based feedstocks, specifically agricultural by-products like corncobs. This approach directly addresses one of the primary ethical concerns surrounding biofuels and biomaterials: the competition for resources between food and industrial applications. By utilizing an abundant, non-food waste stream, Covation aims to create a more circular and responsible supply chain.

The environmental benefits extend beyond feedstock choice. While the company's specific life cycle analysis is proprietary, similar bio-based processes for these chemicals have been shown to reduce greenhouse gas emissions by 30% to as much as 90% compared to traditional petroleum-based manufacturing. This move toward "defossilization" is a key driver for brands and consumers seeking to lower their carbon footprint.

The production of Xatryx® represents a tangible shift from a linear, extractive model to a more circular, regenerative one, where annually renewable resources form the foundation of industrial production.

Navigating a Competitive and Growing Market

Covation Biomaterials is entering a dynamic and increasingly competitive landscape. The global market for PTMEG was valued at approximately USD 2.9 billion in 2025 and is projected to grow steadily. While the bio-based segment is still nascent, it is expanding at an impressive compound annual growth rate (CAGR) of around 8%, with some analysts projecting the bio-PTMEG market to reach USD 2.5 billion by 2032.

Demand is fiercely driven by the Asia-Pacific region, which dominates global spandex production for the apparel industry. This makes Covation’s choice of location for its flagship plant a highly strategic one. However, the company is not alone. Established chemical giants like Germany's BASF and Japan's Mitsubishi Chemical Corporation are also heavily investing in their own bio-based PTMEG offerings. BASF, for instance, has been producing a form of bio-based PTMEG since 2015, utilizing a fermentation process. Other innovators, like Geno, have focused on producing the bio-based precursor BDO, further fueling the industry's shift.

Covation's large-scale production and proprietary technology are its primary weapons in this competitive arena, aiming to secure a significant share of the burgeoning demand for sustainable materials.

China's Strategic Role in the Bio-Industrial Revolution

The scale of the Qidong project underscores its strategic importance. The RMB 10 billion total investment is planned across three phases, ultimately targeting a massive 500,000 tons per year of bio-based materials. This places the facility among the world's most significant biomaterial production sites and signals a strong bet on the future of the bio-economy.

Locating this mega-plant in Jiangsu Province places Covation at the heart of its target market. China is not only the world's largest consumer of PTMEG, largely due to its sprawling textile industry, but its government is also actively promoting green manufacturing and the development of advanced materials under policies like "Made in China 2025." The investment is expected to bring substantial economic benefits to the Qidong region, including job creation and the development of a high-tech industrial ecosystem.

By building a world-class facility in China, Covation Biomaterials is not just manufacturing a product; it is embedding itself within the world's most critical supply chain for performance textiles and materials, positioning itself to lead a transformation from a fossil-fueled past to a bio-based future.